Examining Symptom-Specific Effects of Omega-3 Fatty Acids in Children with ADHD / ASD Symptoms and Sleep Problems: a Network Approach.

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Our study aims to determine whether omega-3 fatty acid supplementation can improve sleep, mood, and behavior in children with sleep problems and symptoms of Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), or both. By using a transdiagnostic approach-focusing on specific symptoms rather than diagnostic labels-we aim to identify which children may benefit most from omega-3 supplementation, thereby enhancing inclusivity. Many previous studies have excluded children with both ASD and ADHD, or those without a formal diagnosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 12
Healthy Volunteers: t
View:

• Autism Spectrum Quotient 10 score \>5 OR Conners 3 Handscored Short Parent Form T score \> 64 for either the inattention OR hyperactivity subscales OR Children Sleep Habits Questionnaire SF score \>30 Able to swallow capsules

Locations
Other Locations
United Kingdom
FHMLS
RECRUITING
Swansea
Contact Information
Primary
Hayley Young, PhD
h.a.young@swansea.ac.uk
01792295607
Backup
David Benton, PhD
d.benton@swansea.ac.uk
Time Frame
Start Date: 2024-11-07
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 200
Treatments
Experimental: Active intervention
Supplement
Experimental: Placebo intervention
Supplement
Sponsors
Leads: Swansea University

This content was sourced from clinicaltrials.gov